Background and Objective. Sentinel lymph node (SLN) biopsy efficiency has been confirmed in various solid tumors. This study aimed to assess SLN biopsy feasibility in clinical application and explore how to improve its detection rates and diagnostic accuracy in cervical cancer laparoscopic surgery. Methods. A total of 100 cervical cancer patients undergoing laparoscopic surgery with SLN biopsy were included. Indocyanine green, carbon nanoparticles (CNPs), and a combination of both were used during surgeries. Detection rates, sensitivity, negative predictive value (NPV) of SLN biopsy, and related factors were analyzed. Results. The overall and bilateral SLN detection rates were 92% (92/100) and 74% (74/100), respectively. Combined tracers had higher bilateral SLN detection rates than CNPs alone ( ). Menopause and lymph node metastasis were associated with lower overall and bilateral SLN detection rates ( ). SLN biopsy sensitivity and NPV for lymph node metastasis in patients with at least one detected SLN were 81.8% (9/11) and 97.3% (72/74), respectively. Among those with bilateral detected SLNs, higher sensitivity and NPV of 87.5% (7/8) and 98.3% (57/58) were observed, respectively. SLN algorithm can ensure that all patients with lymph node metastasis are detected by SLN biopsy. Conclusion. SLN biopsy appears to be safe and effective for specific cervical cancer patients with high detection rates and NPV in laparoscopic surgery, especially for those with detected bilateral SLNs and undergoing the SLN algorithm. Selecting suitable patients for SLN mapping has prospects for clinical application.
Background: Laparoscopy for early/low-risk endometrial cancer (EC) is safe, but evidence for high-risk cases is insufficient. This study aimed to compare perioperative safety and survival outcomes between high-risk EC patients receiving laparoscopic surgery and laparotomy. Methods: A total of 267 high-risk EC patients (stage IA, grade 3; stage IA, type II tumors; stage IB-III, regardless of histologic grade) undergone surgery in Peking University People’s Hospital from 2006 to 2016 were retrospectively enrolled in the study. To evaluate the safety of laparoscopic surgery, the incidence of perioperative complications and long-term oncological outcomes were compared between patients receiving laparoscopic surgery or laparotomy. Survival analysis was performed using the Kaplan-Meier method and Cox regression. Results: Laparoscopic approach was associated with shorter mean operative time (183.0±60.3 vs. 202.3±67.0 mins, P=0.02), less blood loss (210.2±255.5 vs. 484.9±328.2 mL, P<0.001) and lower transfusion rate (10.4% vs. 31.6%, P<0.001) than laparotomy. Both Kaplan-Meier method and univariate Cox regressions showed that laparoscopic surgery and laparotomy had similar 5-year disease-free (88.8% vs. 84.6%, P=0.33) and overall survival (95.6% vs. 90.2%, P=0.58). In multivariate analysis, both stage and grade were associated with oncological outcomes whereas surgical approach was not a risk factor for prognosis. Conclusions: Laparoscopic surgery is effective and safe in high-risk EC, though further validations by randomized clinical trials are needed.